急性冠状动脉综合征患者血清ICAM-1、VCAM-1及CD40L水平及葛根素对其的影响

马爱玲; 邵宁; 伊善喜; 王玉宝; 刘忠伦; 吴兆增

doi:10.13201/j.issn.1001-1439.2014.06.009

急性冠状动脉综合征患者血清ICAM-1、VCAM-1及CD40L水平及葛根素对其的影响

- 1 连云港市东方医院心内科(江苏连云港, 222042);
- 2 江苏省连云港市东方医院临床实验中心
基金项目:
江苏省连云港市卫生局青年科技基金 (No:Q1211)

详细信息

通讯作者: 吴兆增,E-mail:wuzlyg@163.com

中图分类号: R541.4

收稿日期: 2014-02-23

The serum content variety of ICAM-1,VCAM-1,CD40L in acute coronary syndrome patients and the effect of Puerarin

- 1 Department of Cardiology, Easth Hospital in Lianyungang City, Lianyugang, 222042, China;
- 2 Clinic Laboratory Center, Easth Hospital in Lianyungang City, Lianyugang, 222042, China

More Information

Corresponding author: WU Zhaozeng, E-mail: wuzlyg@163.com

Received Date: 23 February 2014

摘要

摘要: 目的:探讨急性冠状动脉综合征 (acute coronary syndrome, ACS) 患者血清细胞间黏附分子-1 (ICAM-1)、血管细胞黏附分子-1 (VCAM-1) 及CD40L水平变化及葛根素对其的影响, 研究黏附分子在ACS中的作用, 进一步探讨中药葛根素治疗冠心病的作用机理。方法:采用酶联免疫ELISA法测定ACS患者及非ACS者葛根素治疗前后血清ICAM-1、VCAM-1及CD40L水平, 对两组数据进行比较。结果:治疗前, ACS组血清ICAM-1、VCAM-1及CD40L水平显著高于稳定性冠心病组和对照组 (均P＜0.01);治疗后, ACS葛根素组血清ICAM-1、VCAM-1及CD40L水平较ACS对照组下降显著 (P＜0.01)。结论:ICAM-1、VCAM-1及CD40L等炎性因子共同作用促进ACS的发生、发展, 葛根素可能通过抑制该类炎性因子的表达来抑制急性血栓形成的作用。
- 急性冠状动脉综合征 /
- 细胞间黏附分子1 /
- 血管细胞黏附分子1 /
- 葛根素
Abstract: Objective: To discuss the serum content variety of ICAM-1, VCAM-1, CD40L in acute coronary syndrome (ACS) patients, and the effect of Puerarin;Investigate the function of the cell adhesive molecule in ACS, and then explore the mechanism of Puerarin.Method: Enzyme-linked immunosorbent assay (ELISA) was used to measure the content of soluble ICAM-1, VCAM-1, CD40L in ACS patients and non-ACS controls, as well as in ACS patients with Puerarin therapy and ACS controls.The differences of ICAM-1, VCAM-1, CD40L content were compared.Result: The levels of ICAM-1, VCAM-1, CD40L were significantly higher in ACS patients than those in controls, and was significantly lower in ACS patients with Puerarin therapy than those with conventional treatment.Conclusion: The combined action of inflammatory factors just as ICAM-1, VCAM-1, CD40L promote ACS, and Puerarin probably passes to repress the expression of inflammatory factor and has the action that repress the acute thrombosis.
- acute coronary syndrome /
- ICAM-1 /
- VCAM-1 /
- Puerarin

HTML全文

参考文献(6)

[1]	李守贵.ACS患者血清sICAM.1、sVCAM-1、可溶P选择素的水平变化及意义[J].山东医药, 2009, 49 (17):84-85.
[2]	申文祥, 党瑜华, 陈魁, 等.冠状动脉粥样硬化性心脏病患者血浆可溶性细胞间粘附分子-1和可溶性血管细胞粘附分子-1水平检测[J].郑州大学学报 (医学版), 2007, 42 (3):546-548.
[3]	李丰伟, 施陈刚.CD40一CD40L系统与易损斑块的破裂[J].中国分子心脏病学杂志, 2008, 8 (4):249-252.
[4]	YAN J C, WU Z G, KONG X T, et al.Relation between upregulation of CD40 system and complex stenosis morphology in patients with acute coronary syndrome[J].Acta Pharmacol Sin, 2004, 25:251-256.
[5]	WU M, LI Y G.The expression of CD40-CD40L and activities of matrix metalloproteinases in atherosclerotic rats[J].Mol Cell Biochem, 2006, 282:141-146.
[6]	MACH F, SCHONBECK U, SUKHOVA G K, et al.Reduction of atherosclerosis in mice by inhibition of CD40 signalling[J].Nature, 1998, 394:200-203.